A drug that targets those receptors could improve memory in Alzheimer's disease
January 27, 2015
Gladstone Institutes researchers have uncovered a new memory regulator in the brain that may offer a potential treatment to improve memory in Alzheimer’s disease using a drug that targets those receptors.
They found in their research* that decreasing the number of A2A adenosine receptors in astrocyte brain cells improved memory in healthy mice. It also prevented memory impairments in a mouse model of Alzheimer’s disease.
The findings were published Monday (Jan. 26) in Nature Neuroscience./.../